Regulatory & Legal

A 10-year, $25M program created 108 palliative care leaders. A new report reveals its impact on a field facing a critical workforce and access crisis.

Biopharma toolmaker Ensorcell appoints Geoff Hodge and Amy Teachout, signaling a strategic move to disrupt the market with affordable, US-made innovation.

A South Florida group is skipping the fancy awards dinner to honor women leaders in their own workplaces, proving that the most meaningful praise is personal.

A unique $4M award program aims to solve a critical funding gap, accelerating high-risk, high-reward cancer therapies from academic labs to patients.

A new MMA league is letting fans and fighters buy in. With veteran leaders and a $5M equity raise, can the Global Fight League disrupt the octagon?

A new partnership embeds real-time tax determination into spend management, aiming to eliminate compliance risks and streamline financial workflows.

SEAM, Inc. appoints a new COO and CMO, signaling a strategic move to scale its social equity certification and meet the growing demand for people-first real estate.

Cherry Hill facility's Joint Commission accreditation signals a new benchmark for quality and safety in addiction recovery for New Jersey families.

Securus Monitoring touts high-tech supervision tools for modern reentry, but its parent company's controversial history casts a long shadow over its promises.

A new partnership in Brazil will use light-powered tech to turn agricultural waste into SAF, part of a plan to build a 1M ton global supply chain.

The organic food pioneer gets 37 products certified under a new standard, signaling a major shift toward transparency in the fight against ultra-processed food.

With $65M in new funding and a new CEO, Duos is betting big on a $200M NVIDIA GPU deal to become a key player in the booming Edge AI infrastructure market.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

With a 10-K filed and new acquisitions, THC Therapeutics is fighting to shed its obscure market status and build a vertically integrated cannabis powerhouse.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

The aerial firefighting giant lands a major DOI contract for Alaskan transport, signaling a strategic shift into year-round government logistics.

The neurohealth firm surpassed revenue estimates and hit positive cash flow, but a dynamic competitive landscape and CEO transition loom ahead of its earnings call.

A new deal brings Nanox's low-radiation, cost-effective Nanox.ARC to orthopedic clinics, aiming to reshape point-of-care diagnostics in the region.

A new partnership between Dstillery, Keynes, and The Trade Desk cuts a 48-hour workflow to 5 minutes, heralding a new era of autonomous AI in advertising.